Open AccessRisk factors of contrast-induced nephropathy in patients with acute coronary syndrome
Author(s) -
Tomasz Rakowski,
Artur Dziewierz,
Michał Węgiel,
Zbigniew Siudak,
Wojciech Zasada,
Jacek Jąkała,
Dominika Dykla,
Jerzy Matysek,
Andrzej Surdacki,
Stanisław Bartuś,
Dariusz Dudek,
Roman Wojdyła
Publication year - 2022
Publication title -
kardiologia polska
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.527
H-Index - 34
eISSN - 1897-4279
pISSN - 0022-9032
DOI - 10.33963/kp.a2022.0123
Subject(s) - medicine , contrast induced nephropathy , percutaneous coronary intervention , conventional pci , acute coronary syndrome , myocardial infarction , anemia , nephropathy , cardiology , creatinine , diabetes mellitus , endocrinology
Patients with acute coronary syndrome (ACS) are at high risk of contrast-induced nephropathy (CIN), which is associated with prolonged hospitalization, higher morbidity and mortality after angiographic procedures. The occurrence of CIN is regarded as a transient and reversible condition. However, the persistence of CIN until hospital discharge in patients with ACS has not been thoroughly analyzed.